Maximus (NYSE:MMS) Updates FY 2025 Earnings Guidance

Key Points

• Maximus has updated its FY 2025 earnings guidance to an expected earnings per share of 7.350-7.550, higher than the consensus estimate of 6.500, and revenue guidance of $5.4 billion-$5.5 billion, matching the consensus.
• The company recently announced a quarterly dividend of $0.30 per share, which translates to an annual yield of 1.6%, with a dividend payout ratio of 23.86%.
• In market activity, Maximus stock opened at $74.81, has a market cap of $4.22 billion, and institutional investors own approximately 97.21% of the shares.

Maximus (NYSE:MMS - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 7.350-7.550 for the period, compared to the consensus estimate of 6.500. The company issued revenue guidance of $5.4 billion-$5.5 billion, compared to the consensus revenue estimate of $5.4 billion.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.

Maximus Trading Up 1.3%

NYSE MMS traded up $1.09 during trading on Monday, reaching $82.54. 336,251 shares of the stock traded hands, compared to its average volume of 562,328. The firm has a market cap of $4.65 billion, a price-to-earnings ratio of 15.21 and a beta of 0.60. The stock's 50-day moving average price is $71.73 and its 200 day moving average price is $70.40. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91. Maximus has a fifty-two week low of $63.77 and a fifty-two week high of $93.94.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.77. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The company's revenue was up 2.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.74 earnings per share. Analysts predict that Maximus will post 6.15 EPS for the current year.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 1.5%. Maximus's dividend payout ratio (DPR) is currently 22.10%.

Insider Buying and Selling

In other Maximus news, Director Gayathri Rajan sold 7,913 shares of the firm's stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the transaction, the director owned 14,205 shares in the company, valued at approximately $1,028,157.90. This trade represents a 35.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.60% of the stock is currently owned by corporate insiders.

Institutional Trading of Maximus

Hedge funds have recently modified their holdings of the stock. Jane Street Group LLC grew its position in Maximus by 941.2% in the 1st quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider's stock worth $6,701,000 after purchasing an additional 88,835 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Maximus by 7.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider's stock valued at $12,321,000 after purchasing an additional 11,754 shares in the last quarter. Royal Bank of Canada raised its holdings in Maximus by 146.2% in the first quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider's stock worth $1,345,000 after buying an additional 11,716 shares during the last quarter. Cetera Investment Advisers increased its stake in shares of Maximus by 19.8% in the second quarter. Cetera Investment Advisers now owns 5,413 shares of the health services provider's stock worth $380,000 after purchasing an additional 894 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Maximus by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider's stock worth $2,351,000 after buying an additional 221 shares in the last quarter. Institutional investors own 97.21% of the company's stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.